Indomethacin, reduced retinal sensitivity, and corneal deposits.
D000221:Adaptation, Ocular / Q000187:drug effects; D000328:Adult; D000368:Aged; D000792:Angiography; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003315:Cornea / Q000187:drug effects*; D003318:Corneal Opacity / Q000139:chemically induced; D004596:Electroretinography; D004848:Epithelium / Q000187:drug effects; D005128:Eye Diseases / Q000139:chemically induced; D005260:Female; D005453:Fluorescence; D005654:Fundus Oculi; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects*; D008266:Macula Lutea / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D010859:Pigmentation Disorders / Q000139:chemically induced; D012160:Retina / Q000187:drug effects*; D012168:Retinal Pigments / Q000494:pharmacology; D012173:Retinitis / Q000139:chemically induced; D014785:Vision, Ocular / Q000187:drug effects; D014794:Visual Fields / Q000187:drug effects
D012168:Retinal Pigments; D007213:Indomethacin